IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,721,600 | -64.9% | 60,000 | -68.3% | 0.04% | -69.6% |
| Q2 2023 | $7,754,670 | +26.7% | 189,000 | +10.4% | 0.14% | +16.9% |
| Q1 2023 | $6,118,688 | +89.5% | 171,200 | +100.2% | 0.12% | +131.4% |
| Q4 2022 | $3,229,335 | -33.6% | 85,500 | -22.3% | 0.05% | -23.9% |
| Q3 2022 | $4,866,000 | -34.3% | 110,000 | -45.0% | 0.07% | -34.3% |
| Q2 2022 | $7,404,000 | +91.6% | 200,000 | +57.5% | 0.10% | +131.8% |
| Q4 2021 | $3,864,000 | -51.2% | 127,000 | -46.2% | 0.04% | -51.1% |
| Q3 2021 | $7,916,000 | -46.3% | 235,993 | -36.1% | 0.09% | -53.1% |
| Q2 2021 | $14,732,000 | +446.0% | 369,307 | +515.5% | 0.19% | +231.0% |
| Q1 2021 | $2,698,000 | -82.1% | 60,000 | -77.5% | 0.06% | -83.1% |
| Q4 2020 | $15,108,000 | +39.6% | 267,227 | +17.2% | 0.34% | +36.0% |
| Q3 2020 | $10,819,000 | -29.0% | 228,000 | -11.7% | 0.25% | -50.1% |
| Q2 2020 | $15,228,000 | +162.4% | 258,276 | +186.0% | 0.51% | +73.6% |
| Q2 2019 | $5,804,000 | -31.9% | 90,300 | -14.0% | 0.29% | -37.9% |
| Q1 2019 | $8,523,000 | – | 105,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |